Division of Medical Oncology and Hematology (Drs Dhani, Lheureux, and Oza), Princess Margaret Cancer Centre (Mss Jivraj, Tinker, Bowering, Ng, and Buchanan and Dr Lau), Toronto, Ontario, Canada; Royal Hospital for Women and University of South Wales, Randwick, New South Wales, Australia (Dr Lee); Divisions of Gynecologic Oncology (Dr Ferguson), General Surgery (Drs Dhar and Shlomovitz), and Radiology (Dr Shlomovitz), University Health Network (Dr Croke and Mss Karakasis and Stuart-McEwan), Toronto, Ontario, Canada; Departments of Obstetrics and Gynecology (Dr Ferguson), Radiation Oncology (Dr Croke), and Surgery (Drs Dhar and Shlomovitz), and Lawrence S. Bloomberg Faculty of Nursing (Ms Stuart-McEwan), University of Toronto (Dr Oza), Toronto, Ontario, Canada; Mount Sinai Hospital, Toronto, Ontario, Canada (Dr Chawla); and Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada (Dr Chawla).
Correspondence: Nazlin Jivraj, MN, RN, CON(C), Princess Margaret Cancer Centre, University Health Network, 610 University Ave, Toronto, ON M5G 2M9, Canada ([email protected]).
Terri Stuart-McEwan and Dr Stephanie Lheureux are joint senior authors.
The authors are grateful for the support of the multidisciplinary team in gynecologic, general surgery, and palliative care at Princess Margaret Cancer Centre. The authors also thank the Collaborative Academic Practice (CAP) Fellowship Program, the Princess Margaret Cancer Centre Foundation, their patients, and caregivers for their time, knowledge, and support in the development of the MBO program.
The authors have no funding or conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.jncqjournal.com).
Accepted for publication: August 11, 2022
Early Access: October 10, 2022